Funding for this research was provided by:
Received: 13 March 2019
Accepted: 5 May 2020
First Online: 1 June 2020
Ethics approval and consent to participate
: The Bannatyne Campus Biomedical Research Ethics Board (BREB) in Winnipeg, Manitoba, Canada has approved this study protocol (HS19441 (B2016:011). All amendments to this studies protocol are reviewed and approved by the U of M BREB, and changes to the protocol have been updated on ExternalRef removed. This trial is registered at ExternalRef removed (Identifier: NCT02765516). All participants must provide a written informed consent before they are enrolled in this trial, and these consent forms will be dated and signed by participants and an appropriate trial staff prior to participant entry into the trial. Participants sign a general consent to participate in the trial as well as a consent for genetic analysis. Participants receive a copy of the consent forms they have signed.
: All participants provide consent to publish or present their information gathered during the trial in a fashion where their personal information such as their name, address, telephone number and/or any other identifying information are not revealed.
: ET is employed by Upfield™ marketed food products with added plant sterols. All other authors declare that they have no competing interests.